ANRO
Alto Neuroscience, Inc.
26.50$
-2.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 96.1% | 96.8% | 98.6% | 95.4% | 96.2% | |
| 89.3% | 95.1% | 95.3% | 94.8% | 95.6% | |
| 89.3% | 95.1% | 95.3% | 94.8% | 95.6% | |
| 6.1% | 1.1% | 0.0% | – | – | |
| 0.0% | – | – | – | – | |
| 143.3% | 175.5% | 182.7% | 14.7% | 18.2% | |
| 6.3% | 10.9% | 6.5% | 5.6% | 6.1% | |
| – | 0.6% | 0.1% | 0.5% | 0.3% | |
| 2.1% | 3.2% | 1.2% | 0.9% | 1.0% | |
| – | 18.6% | 11.4% | 6.5% | 10.0% | |
| -43.3% | -75.5% | -82.7% | 85.3% | 81.8% | |
| -45.0% | -80.0% | -88.8% | -78.0% | -109.2% | |
| 88.8% | 50.3% | 31.0% | 13.9% | 15.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.